CEA(6D)-TRICOM vaccine (Therion/NCI)

N/A

Report date: 2022/10/14 20:00:43

Base Information

Drug NameCEA(6D)-TRICOM vaccine (Therion/NCI)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursHead and Neck NeoplasmsOvarian Neoplasms +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTherion Biologics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTherion BiologicsNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsSolid tumoursHead and Neck NeoplasmsOvarian Neoplasms +[10] 

Other Information

ATC CodeN/A
Related LinksN/A